DXS International plc's ExpertCare Improves Clinical Outcomes and Saves Costs

DXS International plc’s ExpertCare has been featured in an Innovate UK research project, showcasing its impact on clinical outcomes and NHS cost-efficiency. The study, funded by DXS and Innovate UK, found that ExpertCare significantly improves hypertension control, reduces treatment variability, and is cost-saving in both short and long term. The independent review by YHEC concluded that for every £1 invested, ExpertCare returns £2.70 to the NHS. CEO David Immelman expressed pride in these results, highlighting the potential for ExpertCare to enhance hypertension management nationwide. DXS International provides digital clinical decision support solutions to improve healthcare outcomes efficiently.

Read more at GlobeNewswire: DXS International plc (AQSE:DXSP): ExpertCare featured in